News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery L.A. McKeown March 04, 2022
News Daily News GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds L.A. McKeown March 01, 2022
News Daily News Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT Yael L. Maxwell February 17, 2022
News Conference News THT 2022 Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality Caitlin E. Cox February 07, 2022
News Daily News SCAI-Defined Perioperative MIs Too Numerous to Be Useful in Cardiac Surgery Michael O'Riordan February 03, 2022
News Daily News Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA Yael L. Maxwell January 27, 2022
News Daily News Delayed Care for NSTEMI Linked to Higher Mortality Over 3 Years Yael L. Maxwell January 27, 2022
News Daily News Yet Another US Report Shows Stalled Progress Against CHD Caitlin E. Cox January 19, 2022
News Daily News As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control Caitlin E. Cox January 10, 2022
News Daily News Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines L.A. McKeown December 28, 2021
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Discharge Safe as Early as a Day After Primary PCI for STEMI L.A. McKeown December 15, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Daily News Rapid ESC hs-cTn Algorithms Best 3-Hour Protocol for MI Rule-out: Meta-analysis Yael L. Maxwell November 23, 2021
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021